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ABSTRACT Eps15 homology domain–containing 2 (EHD2) belongs to the EHD-containing 
protein family of dynamin-related ATPases involved in membrane remodeling in the endo-
somal system. EHD2 dimers oligomerize into rings on highly curved membranes, resulting in 
stimulation of the intrinsic ATPase activity. In this paper, we report that EHD2 is specifically 
and stably associated with caveolae at the plasma membrane and not involved in clathrin-
mediated endocytosis or endosomal recycling, as previously suggested. EHD2 interacts with 
pacsin2 and cavin1, and ordered membrane assembly of EHD2 is dependent on cavin1 and 
caveolar integrity. While the EHD of EHD2 is dispensable for targeting, we identified a loop 
in the nucleotide-binding domain that, together with ATP binding, is required for caveolar 
localization. EHD2 was not essential for the formation or shaping of caveolae, but high levels 
of EHD2 caused distortion and loss of endogenous caveolae. Assembly of EHD2 stabilized 
and constrained caveolae to the plasma membrane to control turnover, and depletion of 
EHD2, resulting in endocytic and more dynamic and short-lived caveolae. Thus, following the 
identification of caveolin and cavins, EHD2 constitutes a third structural component of cave-
olae involved in controlling the stability and turnover of this organelle.
INTRODUCTION
Internalization and recycling of cell surface receptors involves mul-
tiple membrane sculpting and budding events in the cell. Proteins 
within the Eps15 homology domain–containing protein family 
(EHDs) have been shown to participate in the remodeling of mem-
branes in the endosomal system (reviewed in Naslavsky and Caplan, 
2011). The mammalian genome encodes four EHDs, EHD1–4, while 
Caenorhabditis elegans and Drosophila each has a single EHD 
gene, rme-1 and Past-1, respectively. EHDs contain an amino (N)-
terminal GTPase (G) domain, followed by a helical domain, a linker 
region, and a C-terminal EHD known to bind to linear Asn-Pro-Phe 
peptide (NPF) motifs (Figure 1A). We previously solved the crystal 
structure of EHD2, revealing that EHDs are dynamin-related pro-
teins involved in nucleotide-dependent membrane remodeling 
(Daumke et al., 2007). EHD2 dimerizes via a conserved interface 
within the G domain and a highly curved membrane-binding site is 
created by the tips of the two opposing helical domains (Figure 1A). 
In addition to residues enforcing sterical hindrance, binding of the 
EHD to the top of the opposing G domain makes the G domain 
bind and hydrolyze ATP rather than GTP. We found that ATP hydro-
lysis was stimulated by liposome binding and oligomerization of 
EHD2 into ring-like structures on a membrane surface, causing re-
modeling of liposomes into highly curved membrane tubules 
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EHD1 as part of the machinery for recycling 
of the transferrin receptor (TfnR) and major 
histocompatibility complex I (MHC-I; Lin 
et al., 2001; Caplan et al., 2002; Naslavsky 
et al., 2004). Much less is known about the 
cellular roles of the other EHDs. Various re-
ports have suggested that EHDs may form 
heterodimers (Galperin et al., 2002; Lee 
et al., 2005; Sharma et al., 2008), and in-
deed both distinct and overlapping func-
tions have been reported for the different 
EHDs (Naslavsky and Caplan, 2011). Se-
quence comparisons indicate EHD2 is the 
most distal member of the EHD family, and 
previous studies suggested an involvement 
in endocytosis of the insulin-responsive 
glucose transporter GLUT4 and the TfnR 
(Guilherme et al., 2004). Interestingly, en-
dogenous EHD2 was identified as being 
associated with caveolae in a mass spec-
trometry–based screen (Aboulaich et al., 
2004). Caveolae are characteristic small in-
vaginations of the plasma membrane found 
abundantly in many cell types (reviewed in 
Bastiani and Parton, 2010). They are en-
riched in cholesterol, sphingolipids, and the 
proteins caveolin1–3 and cavin1–4 and have 
been implicated in various cellular processes 
as signaling domains, endocytic carriers, 
and sensors of membrane tension.
In this study, we aimed to further charac-
terize the cellular function of EHD2. We 
found that EHD2 specifically bound and lo-
calized to caveolae to stabilize and control 
the dynamics of such invaginations at the 
cell surface. The ability of EHD2 to oligomer-
ize and remodel and stabilize membrane 
surfaces was shown to be regulated by ATP 
binding and hydrolysis, which probably re-
flects a common mechanism for the target-
ing and action of EHD proteins.
RESULTS
Endogenous EHD2 specifically binds 
and localizes to caveolae
To identify the precise site of action and cel-
lular role of EHD2, we generated affinity-
purified antibodies against full-length EHD2 
that specifically detected recombinant 
EHD2, but not EHD1, -3, and -4, in immuno-
blotting (see Supplemental Figure S1A). In 
HeLa cells, the antibodies specifically recog-
nized overexpressed green fluorescent pro-
tein (GFP)-EHD2 in tubules and punctate 
structures (Figure S1B). No colocalization 
was seen in cells overexpressing GFP-
tagged EHD1, but, as in untransfected cells, 
punctate structures were labeled. To vali-
date that these structures represent endog-
enous EHD2, we used small interfering RNA (siRNA) to deplete 
EHD2 in HeLa cells, which indeed resulted in ablation of the distinct 
punctate labeling pattern (Figure S1, C and D). To elucidate the 
In C. elegans, RME-1 was shown to be required for recycling of 
the yolk receptor (Grant et al., 2001). A similar involvement in exit 
from the endosomal recycling compartment has been ascribed to 
FIGURE 1: EHD2 localizes specifically to caveolin1-positive caveolae. (A) Schematic domain 
representation, with the positions of specific sequence motifs indicated. The three-dimensional 
structure of dimeric EHD2 (pdb 2QPT) is shown as a cartoon representation with key residues 
discussed in this study shown as red sticks and the nonhydrolyzable ATP analogue as green 
balls. (B) Fluorescence micrograph of HeLa cells stained for endogenous EHD2 and caveolin1. 
Scale bar: 10 μm. In the table, colocalization between EHD2 and indicated proteins is quantified 
from three individual merged images for each experiment (see also Figure S1, E and G, for 
representative images). (C) Equal protein amounts of different tissue lysates were analyzed by 
SDS–PAGE and immunoblotting using antibodies against EHD2, cavin1, and caveolin2. 
(D) Immunoprecipitations of EHD2 and SNX9 from a lysate of lung membranes were separated 
on SDS–PAGE, which was followed by Western blotting with the indicated antibodies. The 
bottom panel shows the Coomassie blue–stained gel. (E) Gallery of images showing immunoEM 
localization of endogenous EHD2 in 3T3-L1 cells. EHD2 associates with vesicular elements with 
the morphology of caveolae (arrows), including characteristic groups of caveolae at the cell 
surface. N, nucleus; PM, plasma membrane. The boxed area in the top panel is shown at higher 
magnification below. Top, right, magnification of EHD2-labeled caveolar structures. Bottom, 
right, double-labeling of EHD2 (10-nm gold) and cavin1-positive membranes (15-nm gold). 
Bottom, left, the immunoEM localization of EHD2 on plasma membrane lawns of 3T3-L1 
adipocytes. EHD2 associates with vesicular profiles of 55- to 70-nm diameter characteristic of 
caveolae. Note the low labeling of flat plasma membrane and negligible labeling of clathrin-
coated pits (double arrows).
1318 | B. Morén et al. Molecular Biology of the Cell
To clarify whether EHD2 had a preference for association with 
internal or surface-associated caveolin1-positive structures, we de-
termined the three-dimensional localization of caveolin1-RFP and 
GFP-EHD2 in living cells using confocal microscopy and image re-
constructions. EHD2 was specifically found at the plasma mem-
brane, at which it colocalized with the surface pool of caveolin1, al-
though caveolin1-RFP was also detected in internal structures 
(Figure 2B). To confirm this observation, we used total internal re-
flection fluorescence (TIRF) microscopy combined with epifluores-
cence microscopy and followed the localization of caveolin1-RFP 
and GFP-EHD2 within the cell. Indeed, EHD2 was mainly detected 
at the cell surface, together with caveolin1 (Figure S3B). Although a 
subset of EHD2- and caveolin1-positive structures were endocy-
tosed, the majority of such structures appeared limited in their lat-
eral diffusion and stably associated with the cell surface over time 
(Figure 2C). To determine whether EHD2 molecules were in continu-
ous exchange or firmly bound to caveolae, we used fluorescence 
recovery after photobleaching (FRAP) microscopy to deplete the 
fluorescence signal in individual caveolae and follow the recovery of 
EHD2 and caveolin1. As previously shown (Thomsen et al., 2002), 
caveolin1 did not recover significantly from bleaching within 10 min. 
In contrast, although the recovery of EHD2 fluorescence was also 
limited, EHD2 recovered considerably faster than caveolin1 within 
this time frame (Supplemental Movie S1 and Figure 2D). This finding 
indicates that caveolae-bound EHD2 has a slow exchange rate and 
rather stably associates with caveolae under these conditions.
Ordered membrane assembly of EHD2 is dependent 
on cavin and intact caveolae
Our data suggested that the membrane structure of caveolae, or 
proteins exposed in this environment, are required for EHD2 recruit-
ment. We therefore used methyl β-cyclodextrin (MβCD), which is 
known to diminish caveolae, by decreasing the cholesterol content 
in the membrane (Rothberg et al., 1992). This treatment resulted in 
loss of both endogenous and overexpressed EHD2, cavin, and ca-
veolin1 in punctate structures, showing that cholesterol and caveo-
lar integrity is crucial for higher-order assemblies of EHD2 (Figures 
3A and S4, A–C). Note that the monoclonal antibody against caveo-
lin1 reacted poorly toward caveolin1 in mouse 3T3-L1 cells, preclud-
ing detection of endogenous EHD2 and caveolin1 in the same cell. 
Shorter treatments with MβCD sometimes shifted the localization of 
endogenous and overexpressed EHD2 to larger tubular structures 
totally separated from caveolin1-positive structures (Figures 3B and 
S4D). This indicates that EHD2 can temporally bind and remodel 
membranes in the absence of intact caveolae, similar to EHD2 ex-
pression in cells without caveolae. Biochemical determination of the 
amount of membrane-bound and cytosolic EHD2 showed that simi-
lar amounts of EHD2 were bound to the membrane in control and 
MβCD-treated cells (Figure S4E). This indicates that ordered EHD2 
assembly, but not EHD2 membrane binding per se, is dependent on 
cholesterol, in agreement with previous liposome-binding experi-
ments using purified EHD2 (Daumke et al., 2007). Following deple-
tion of cholesterol, or other perturbations of caveolar assembly, ca-
veolin1 was recently shown to disperse and become endocytosed 
into endosomes and degraded (Hill et al., 2008; Hayer et al., 2010b); 
however, our data suggest that EHD2 is not involved in this uptake 
due to the lack of colocalization with internalized caveolin1 follow-
ing MβCD treatment.
EHD2 interacts and colocalizes with cavins and pacsin2
The special lipid composition and presence of structural integral 
membrane proteins, such as caveolin, render caveolae difficult to 
nature of the punctate location of EHD2, we colabeled cells using 
the EHD2 antibody and antibodies against markers of various com-
partments. We found extensive colocalization between EHD2 and 
caveolin1-positive punctate structures, indicating that most of the 
membrane-associated EHD2 is found in caveolae (Figure 1B). In 
contrast, we found no colocalization with flotillin (quantified in 
Figures 1B and S1E), which generates specific subdomains in the 
membrane in a manner similar to caveolin1 (Glebov et al., 2006). 
EHD2 has been suggested as functioning in both exit from endo-
somes and clathrin-dependent endocytosis (Guilherme et al., 2004; 
George et al., 2007). However, we found no colocalization with re-
cycling MHC-I molecules or mannose-6-phosphate receptors 
(M6PR). Neither did we observe any colocalization with AP-2–coated 
structures or endocytosed transferrin (Figure S1, F and G). We also 
assayed markers for the endoplasmic reticulum, Golgi, and early 
and late endosomes without finding any significant colocalization 
(Figure S1G).
Consistent with a role of EHD2 at caveolae, EHD2 was highly 
expressed in tissues known to have abundant caveolae, such as lung 
and adipose tissue, in which caveolin and cavin1 are also highly ex-
pressed (Figure 1C). To test whether markers of caveolae can be 
pulled down together with EHD2, immunoprecipitations from a 
membrane pool of mouse lung enriched for caveolin1 were per-
formed. Indeed, caveolin1 was coimmunoprecipitated with EHD2 
from this lysate, showing that EHD2 interacts with caveolin1-positive 
membranes (Figure 1D). To prove that EHD2 is associated with ca-
veolae on the surface, sections of cells were gold-immunolabeled 
with antibodies against EHD2 and cavin1 (Figure 1E). EHD2 associ-
ated with cavin-positive pits and vesicular profiles with the morphol-
ogy of caveolae (Figure 1E, arrows), including characteristic groups 
of caveolae connected to the plasma membrane. This was con-
firmed using plasma membrane lawns labeled with antibodies 
against EHD2. This technique clearly demonstrated the presence of 
EHD2 on caveolae and the absence of EHD2 on flat plasma mem-
brane and clathrin-coated pits (Figure 1E, bottom, left).
EHD2 is firmly and specifically associated with stable 
caveolae on the plasma membrane
Overexpressed EHD2 in HeLa cells localizes to both punctae and 
membrane tubules (Daumke et al., 2007; Figure S1B). The tubular 
localization could be explained by the fact that HeLa cells have 
only low levels of caveolin1 and caveolae, leading to mislocaliza-
tion and membrane tubulation by overexpressed EHD2. To deter-
mine whether caveolin1 expression drives EHD2 to caveolae, we 
analyzed the localization of overexpressed caveolin1–red fluores-
cent protein (RFP) and GFP-EHD2 in HeLa cells. When coex-
pressed, the two proteins showed striking colocalization in punc-
tae, with almost all EHD2 found in caveolae but not in tubules 
(Figures 2A and S2A). GFP-tagged EHD1, -3, and -4 did not colo-
calize with caveolin1-RFP, showing that caveolar localization is a 
specific feature of EHD2 (Figure S3A). Interestingly, the expression 
of GFP- or myc-tagged EHD2, but not a membrane binding–defi-
cient EHD2 mutant (EHD2 K328D), increased the localization of 
caveolin1-RFP, together with cavin1, on the cell surface (Figures 2A 
and S2, C and D). When expressed at high levels, caveolin1-RFP is 
known to accumulate in the endoplasmic reticulum and lysosomes 
and to aggregate due to improper sorting and assembly at the 
plasma membrane. Following ubiquitylation, unassembled caveo-
lin1 is rapidly internalized for degradation (Hayer et al., 2010b; 
Figure 2A). Our results indicate that membrane-bound EHD2 con-
fines caveolin1 to the surface via recycling or retention at the 
plasma membrane.
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FIGURE 2: EHD2 is stably associated with steady caveolae on the plasma membrane. 
(A) Epifluorescence micrographs of HeLa cells expressing caveolin1-RFP together with myc-
EHD2 (top) or the membrane binding–deficient mutant myc-EHD2 K328D (bottom). (B) Confocal 
sections of living 3T3-L1 cell transfected with GFP-tagged EHD2 and RFP-tagged caveolin1. 
Bottom and side projections show slices of the merged maximum projections at position 
indicated by yellow cross-hairs at 90° rotation. Note the colocalization at the cell surface. 
(C) Representative fluorescence micrographs of 3T3-L1 cells transfected with GFP-EHD2 and 
caveolin1-RFP and analyzed by TIRF microscopy for 4 min with images taken every second. 
Structures positive for EHD2 and caveolin1 were schematically tracked at the indicated time 
points (green circles) and overlaid on the schematic illustration of structures at time zero (gray 
circles). Disappearing structures symptomatic of endocytosis are indicated by red arrowheads. 
(D) FRAP microscopy of 3T3-L1 cell transfected with GPF-EHD2 and caveolin1-RFP. Distinct 
caveolae enriched in both proteins were bleached (yellow circle) and the time-dependent 
recovery of the fluorescence signal in this area was traced as indicated in the diagram below. 
Bar graph showing FRAP of GFP-EHD2 and caveolin1-RFP after 8 min as quantified from three 
independently bleached regions. Error bars represent SD. All scale bars: 10 μm.
analyze with traditional biochemical approaches. However, EHD2 
and cavin1 are peripheral membrane proteins, which allowed us to 
determine whether these proteins interacted using immunoprecipi-
tation. We prepared membranes from mouse lung and dissolved 
them in 0.5% NP40 and high salt to wash EHD2 off the caveolar 
membrane; this was followed by immuno-
precipitation of EHD2 and sorting nexin 9 
(SNX9, a control protein that associates with 
clathrin-coated pits). Cavin1 was immuno-
precipitated together with EHD2 but not 
together with SNX9 (Figure 3C). In agree-
ment with this, we found that recombinant 
EHD2 coupled to beads could specifically 
pull down cavin1 from a lung lysate (Figure 
3D). In addition, we identified pacsin2 as an 
EHD2-associated protein. Pacsin2 was re-
cently found to remodel caveolar mem-
branes and influence the shape of caveolae 
(Hansen et al., 2011; Senju et al., 2011). 
Using the EHD of EHD2 as bait, we con-
firmed that this domain is responsible for 
binding to pacsin2, which in pull-downs 
from lung lysates is the major interaction 
partner of the EHD (Figure 3E). Using iso-
thermal titration calorimetry (ITC), we found 
that one EHD2 dimer binds to one pacsin2 
molecule with an affinity of 37 μM (Figures 
3F and S5, A–D). This interaction did not de-
pend on the SH3 domain of pacsin2 but on 
the integrity of the three NPF motifs, which 
is in agreement with previous studies show-
ing that EHDs of EHD proteins interact with 
the NPF motifs of pacsins (Braun et al., 
2005). Furthermore, two isolated EHDs also 
bound to one pacsin2 molecule with some-
what lower affinity, indicating that dimeriza-
tion of EHD2 can increase the avidity for its 
substrate.
Pacsin2 and all four members of the 
cavin protein family (cavin1–4) localize to ca-
veolae and have partially overlapping func-
tions (Hill et al., 2008; Bastiani et al., 2009; 
Hansen et al., 2009; McMahon et al., 2009; 
Senju et al., 2011). To test whether EHD2 
localizes to caveolae together with pacsin2 
and the cavins, we coexpressed EHD2 to-
gether with individual cavins and stained for 
pacsin2 or caveolin1 (Figures 3G and S5E). 
We found a robust colocalization of EHD2 
with all four cavins on caveolae. Interest-
ingly, we observed that pacsin2 only colo-
calized with a subset of EHD2- and caveo-
lin1-positive structures, but, in addition, 
decorated structures devoid of both EHD2 
and caveolin1 (Figure 3G). Taken together, 
these results suggest a tight interplay of 
EHD2, cavins, and pacsin2 at caveolae. 
However, while EHD2 and cavins can be 
considered as general components, pacsin2 
appears to be only temporary recruited or 
localized to a specific subset of caveolae.
The KPF loop, but not the EHD, is required 
for caveolar targeting
Oligomerization of EHD2 as a result of membrane binding and in-
teractions between the G domains of EHD2 dimers (Figure 4A) was 
proposed to activate ATP hydrolysis (Daumke et al., 2007). The 
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EHDs were shown to localize to the “top 
binding site” of the opposing G domain, 
at which they also bind to a GPF motif in 
the linker region between the helical do-
main and EHD. At that position, the EHDs 
sterically block oligomerization of the G 
domains. It was suggested that switching 
of the EHDs to a KPFxxxNPF motif (resi-
dues 120–128) in a disordered loop at 
the side of the G domain releases autoin-
hibition and promotes oligomerization. 
(Daumke et al., 2007; Figure 4A). To assay 
whether transition of the EHD to the 
KPFxxxNPF motif is indeed required for 
caveolar localization, we expressed a mu-
tant in the motifs (EHD2 F122A/F128A) 
that was previously shown to lack mem-
brane-stimulated ATPase activity (Daumke 
et al., 2007). Surprisingly, this mutant was 
unable to localize to caveolae and did not 
affect the localization of endogenous ca-
veolin1 (Figure S6A). We further assayed 
the F122A and F128A mutations individu-
ally, as well as mutations in nearby amino 
acids in the unstructured loop. The F128A 
mutant behaved in a manner similar to 
wild-type EHD2, whereas the F122A and 
K120N mutants were found in punctate 
and tubular structures distinct from caveo-
lin1-positive structures (Figures 4B and 
S6B). We conclude that the KPF motif is 
required for caveolar targeting.
In one possible scenario, binding of the 
EHD to the KPF loop relieves an autoinhibi-
tory interaction and/or promotes stable oli-
gomerization of the adjacent G domains. 
Alternatively, the KPF loop is directly in-
volved in caveolar targeting by binding to 
another caveola-specific protein. To distin-
guish between these possibilities, we gen-
erated EH deletion mutants in the context 
of wild-type EHD2 (EHD2 ΔEH1–416) or the 
F122A mutant (EHD2 F122A/ΔEH1–416). 
Strikingly, the ΔEH mutant localized to cav-
eolae in a manner similar to wild-type EHD2 
indicating that, in contrast with other EHDs 
(Caplan et al., 2002; Galperin et al., 2002; 
George et al., 2007; Sharma et al., 2008), 
the EHD of EHD2 is not required for proper 
targeting. Interestingly, EHD2 F122A/ΔEH 
did not colocalize with caveolin1 (Figure 4, 
C and D), indicating that it is not the release 
of an autoinhibitory action of the EHD from 
the top site that is responsible for the miss-
ing membrane targeting of the F122A mu-
tant. To determine whether the KPF loop is 
directly involved in caveolar targeting, we 
assayed whether recombinant EHD2 and 
EHD2 F122A attached to beads could bind 
to caveolae from detergent-solubilized 
membranes. EHD2, but not glutathione S-
transferase (GST), bound to caveolae, and 
FIGURE 3: EHD2 interacts and colocalizes with pacsin2 and cavin1, and caveolar membrane 
integrity is required for ordered membrane assembly of EHD2. (A and B) Fluorescence 
micrographs of 3T3-L1 cells coexpressing GFP-EHD2 and caveolin1-RFP and treated with 
15 mM MβCD for 5 or 15 min or PBS (control). Insets in (B) show magnifications of the boxed 
area. (C) Immunoprecipitates of EHD2 and SNX9 from mouse lung lysates were analyzed by 
SDS–PAGE and immunoblotting with antibodies against the indicated proteins. (D and E) 
Pull-down experiments from lung lysate using purified GST, EHD2, or GST-tagged EHD of 
EHD2 coupled to Sepharose beads were analyzed by SDS–PAGE Coomassie blue staining and 
immunoblotting with antibodies against cavin1 and pacsin2. * indicates degraded EHD2 
protein. (F) Table showing the dissociation constants and stoichiometry for the interaction of 
EHD2 with pacsin2 obtained by ITC. See also Figure S5. (G) Fluorescence micrographs of 
3T3-L1 cells coexpressing myc-EHD2 and GFP-cavin1 and costained for endogenous 
caveolin1 (top panel), or GFP-EHD2 and caveolin1-RFP and costained for endogenous 
pacsin2 (bottom panel). Insets show merged image magnifications of areas indicated by 
yellow rectangles. White arrowheads indicate structures positive for all three proteins. All 
scale bars: 10 μm.
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Nucleotide binding is required for 
caveolar localization of EHD2, and 
ATP hydrolysis promotes remodeling 
of caveolae
The ATP-dependent membrane-remodeling 
activity of EHD2 suggested that EHD2 could 
be involved in the dynamics and turnover of 
caveolae. To clarify the role of ATP binding 
for caveolar targeting, we overexpressed an 
EHD2 mutant of the phosphate-binding 
loop (EHD2 T72A), which is unable to bind 
nucleotides (Daumke et al., 2007). Indeed, 
this mutant was incapable of binding mem-
branes and localizing to caveolae (Figure 5, 
A and B). This is in agreement with previous 
work in which we showed that oligomeriza-
tion of EHD2 and subsequent membrane 
remodeling requires nucleotide binding in 
vivo and under stringent in vitro conditions 
(Daumke et al., 2007). To address the role 
of ATP hydrolysis for the function of EHD2 
at caveolae, we assayed the effect on 
caveolin1 following expression of EHD2 or 
EHD2 mutants with no or decreased ATPase 
activity (EHD2 T94A, EHD2 H192D, and 
EHD2 K193D) or EHD2 F122A (Daumke 
et al., 2007). Interestingly, using immunob-
lotting, we found that endogenous caveo-
lin1 was significantly down-regulated in 
EHD2-overexpressing cells (Figures 5, C and 
D, and 7C). EHD2, however, localized spe-
cifically to the remaining caveolin1-positive 
structures, and showed colocalization com-
parable with that of caveolin1-RFP (Figures 
5, A and B). The level of endogenous EHD2 
or cavin1 was not notably altered by the 
overexpression of GFP-tagged EHD2 vari-
ants (Figure 5C). Expression of EHD2 T94A 
also lowered the amount of endogenous ca-
veolin1 to 58% of control cells and, in addi-
tion, affected the localization of both en-
dogenous and overexpressed caveolin1, 
with fewer and larger aggregated structures 
or tubules (Figure 5A). Expression of other 
mutants with decreased ATPase activity 
(EHD2 K193D and EHD2 H192D) also 
showed this distortion of caveolae (Figure 
S7A). This indicates that in the absence of 
stimulated ATPase activity, caveolar mor-
phology is disturbed by an increased mem-
brane-remodeling activity of EHD2. Indeed, 
we observed that caveolin1-positive membranes were heavily tubu-
lated by EHD2 T94A protein in some cells (Figure 5E). To investigate 
the effect of EHD2 overexpression at the ultrastructural level, baby 
hamster kidney (BHK) cells, which enable high transfection effi-
ciency, were transfected with GFP-EHD2, GFP-EHD2 T94A, or GFP 
as a control. All constructs were expressed in more than 80% of 
cells, as judged by light microscopy. The cell surface was labeled 
with ruthenium red to allow the identification of surface-connected 
structures in thin sections. Caveolae were readily identified in con-
trol BHK cells as single pits or characteristic rosettes (Figure 6A). 
Expression of GFP-EHD2 and GFP-EHD2 T94A caused a consistent 
the F122A mutant was drastically impaired in caveolar binding, indi-
cating that the KPF motif, but not oligomerization, is directly required 
for caveolar binding (Figure 4E). We next assayed the stability of the 
EHD2 F122A assemblies devoid of caveolin using FRAP microscopy. 
Membrane assembly of this mutant in tubules and punctae was found 
to be strikingly dynamic in comparison with wild-type EHD2, with al-
most complete recovery after 15 s (Supplemental Movie S2 and 
Figure 4F). Taken together, our data suggest that loop-mediated tar-
geting and further assembly of EHD2 leads to stable association with 
caveolae. Without this specificity, EHD2 demonstrates dynamic mem-
brane binding and membrane remodeling.
FIGURE 4: The KPF loop in EHD2 mediates targeting to caveolae and stable membrane 
assembly of EHD2. (A) Schematic illustration of the previously proposed oligomerization model 
of EHD2 and subsequent stimulation of ATP hydrolysis. Top views of three EHD2 dimers shows 
the proposed transition of the EHDs from the top site of the GTPase domain to the KPF loop of 
the GTPase domain. (B and C) Fluorescence micrographs of 3T3-L1 cells coexpressing GFP-
tagged EHD2 variants and caveolin1-RFP. The ΔEH mutant comprises residues 1–416. 
(C) Colocalizing pixels are shown on the right panels. (D) Bar graph showing quantification of the 
extent of colocalization between GFP-tagged EHD2 variants and caveolin1-RFP using three 
individual merged images for each construct. Error bars represent SD. (E) Pull-down 
experiments from caveolae-enriched membranes using purified GST, EHD2, or EHD2-F122A 
coupled to Sepharose beads were analyzed by SDS–PAGE and immunoblotting with antibodies 
against caveolin1 and EHD2. (F) FRAP microscopy of 3T3-L1 cell transfected with GPF-EHD2 
F122A and caveolin1-RFP. The indicated area (yellow circle) was bleached and the time-
dependent recovery of the fluorescence signal in this area was traced as shown in the diagram 
below. Bar graph showing FRAP of GFP-EHD2 and GFP-EHD2 F122A after 15 s as quantified 
from three independently bleached regions for each protein. Error bars represent SD. All scale 
bars: 10 μm.
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decrease in the density of surface caveolae 
(Figures 6, A and B). The remaining caveolae 
in the majority of cells showed normal mor-
phology. However, highly expressing GFP-
EHD2 cells showed striking accumulations 
of tubules, some of which were ruthenium 
red–labeled and therefore surface-con-
nected (Figure 6A, black arrows), while oth-
ers were of similar morphology but appar-
ently disconnected from the cell surface 
(Figure 6A, white arrows).
Caveolae still form in cells depleted 
of EHD2
Loss of cavin1 has been shown to result in 
ablation of caveolae. To assay whether loss 
of EHD2 affected caveolae in 3T3-L1 cells, 
we used siRNA to deplete the levels of 
EHD2 and cavin1 (Figure 7A). We verified 
that we had at least 98% knockdown effi-
ciency of EHD2 using siRNA by immunopre-
cipitating EHD2 from cells before immunob-
lotting (Figure 7A). When siRNA-treated 
cells were assayed by immunofluorescence, 
we found that the characteristic EHD2 stain 
was completely ablated (Figure 7B). Strik-
ingly, caveolin1 localization and intensity ap-
peared similar to that of cells treated with 
control siRNA. To verify that caveolin1 and 
cavin1 still localized to detergent-resistant 
caveolar membranes, we used siRNA to de-
plete EHD2 or cavin1, lysed the cells in 1% 
ice-cold Triton-100, and separated the 
membrane microdomains from dissolved 
membranes and cytosol by centrifugation. 
The pellet fraction (membrane microdo-
mains) and supernatant were analyzed by 
immunoblotting to detect EHD2, cavin1, 
and caveolin1. As expected, depletion of 
cavin1 drastically reduced the amount of 
both caveolin1 and EHD2 in the pellet frac-
tion due to the loss of caveolae (Figure 7, C 
and D). The total amount of caveolin1 was 
reduced, as previously shown (Hill et al., 
2008). However, when EHD2 was depleted, 
we detected a slight increase (32%) in cave-
olin1 levels. (Figure 7C). These data suggest 
that caveolae can still form in the absence of 
EHD2 or that the already formed caveolae 
were stable. To assay whether cells depleted 
of EHD2 were able to form new caveolae, 
FIGURE 5: ATP-binding is required for EHD2 targeting, and ATP hydrolysis regulates the 
membrane-remodeling activity of EHD2. (A) Fluorescence micrographs of 3T3-L1 cells 
expressing GFP-tagged EHD2 variants and costained for endogenous caveolin1. 
(B) Quantification of the extent of colocalization between GFP-tagged EHD2 variants and 
endogenous caveolin1 or caveolin1-RFP. Three individual merged images from each experiment 
were normalized and the percentage of EHD2 structures that colocalized with caveolin1 or 
caveolin1-RFP were determined. ICQ values representing the extent of correlation in staining 
intensity (−0.5 [minimum] to 0.5 [maximum]) between GFP-tagged EHD2 variants and caveolin1-
RFP were determined as described in Materials and Methods. (C) Immunoblot analysis of total 
protein levels in 3T3-L1 cells following overexpression of indicated GFP-tagged EHD2 variants. 
(D) Quantification of the levels of 
endogenous EHD2 and caveolin1 from three 
independent experiments as in (C). Error bars 
indicate the SD. (E) Fluorescence micrograph 
of cells coexpressing the ATP hydrolysis–
deficient mutant GFP-EHD2 T94A and 
caveolin1-RFP showing heavily tubulated 
caveolin1-positive membranes colabeled with 
GFP-EHD2 T94. Insets show magnifications 
of indicated areas. All scale bars: 10 μm.
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oxidase (CTxB-HRP) for 1 min and then quantification of budded 
caveolae (defined as 55- to 75-nm uncoated profiles) via the diamin-
obenzidine (DAB) reaction in the presence of a surface-quenching 
agent (Kirkham, 2005). Interestingly, in comparison with control 
cells, EDH2-depleted cells displayed 2.5 times more internalized 
caveolae at this time point (Figure 8, A and B). Using dynasore treat-
ment to block dynamin resulted in greatly reduced caveolar endo-
cytosis, as previously described (Figure 8B; Boucrot et al., 2011). 
We observed that the total number of surface-connected caveolae 
was slightly increased in cells lacking EHD2, in contrast with cells 
overexpressing EHD2 (Figure 8C). These data suggest that the more 
dynamic endocytic caveolae might fuse back to the plasma mem-
brane more efficiently in the absence of EHD2, resulting in more 
caveolae at the surface. We detected no obvious morphological 
phenotypic changes in caveolae following EHD2 depletion (unpub-
lished data). To address whether EHD2 stabilized caveolae at the 
plasma membrane, we used TIRF microscopy to look at the dynam-
ics of surface-associated caveolin1-RFP following expression of 
GFP-EHD2 or GFP-EHD2 K328D. Strikingly, cavolin1-RFP was highly 
dynamic on the surface when expressed together with the mem-
brane binding–deficient GFP-EHD2 K328D, which likely functions to 
sequester endogenous EHD2 (Supplemental Movie S3, A and B, 
and Figure 8D, bottom). However, in cells expressing GFP-EHD2, 
caveolin1-RFP was found together with EHD2 in structures that were 
very stable and did not show any apparent membrane diffusion 
(Supplemental Movie S4, A and B, and Figure 8D, top). These re-
sults indicate that EHD2 is needed to stabilize caveolae at the sur-
face and suggested that such structures are spatially constrained, 
possibly through coupling to the cytoskeleton. On the basis of our 
results, we propose a model in which ATP binding and the KPF loop 
target EHD2 to caveolae, and subsequent oligomerization of EHD2 
sculpts the caveolar membrane to stabilize caveolae at the cell sur-
face and control scission from the membrane (Figure 8E).
DISCUSSION
EHDs are widely used in trafficking processes throughout the cell, 
but little is known about their detailed cellular function and the de-
terminants that mediate specificity in their recruitment to particular 
trafficking pathways. In this paper, we show that EHD2, but not 
other EHDs, is specifically associated with caveolae at the cell sur-
face. Ordered membrane assembly of EHD2 was dependent on 
ATP binding and caveolar integrity. Interestingly, the unstructured 
KPF loop at the periphery of the G domain is directly involved in 
targeting of EHD2 dimers to caveolae. Recruitment could be medi-
ated via proteins exposed on the surface of caveolae and influenced 
by the specific lipid composition and membrane curvature of cave-
olae. Immobilized EHD2 was able to pull down caveolae in vitro, 
demonstrating that EHD2 dimers are sufficient for caveolar binding. 
Due to the biochemical properties of caveolin1, analysis of direct 
interactions with EHD2 was precluded. However, EHD2 was found 
to interact with cavin1 and pacsin2, suggesting a direct association 
with core components of caveolae. Binding to pacsin2 was medi-
ated via the EHD, but targeting of EHD2 to caveolae was indepen-
dent of the EHD, indicating that pacsin2 is not responsible for re-
cruiting EHD2. In contrast to other EHDs (Kieken et al., 2010), the 
EHDs might rather be involved in the intramolecular control of EHD2 
activity and, possibly, subsequent protein interactions at caveolae. 
Consistent with these findings, Hansen et al. recently reported that 
GFP-EHD2 localized to morphologically defined caveolae as seen 
by immunoelectron microscopy (immunoEM; Hansen et al., 2011).
At the plasma membrane, caveolin1-enriched domains adopt the 
typical invaginated structure of caveolae in a cholesterol-, caveolin1-, 
we removed caveolae by MβCD treatment and analyzed the recov-
ery of caveolae after washing away the drug. In control cells, as well 
as in EHD2-depleted cells, caveolae started to reappear after 30 
min and had fully recovered after 2 h (Figure 7E). Taken together, 
these data showed that caveolae are present in cells lacking EHD2 
and that caveolar structures can re-form in the absence of EHD2 
after restoration of cholesterol levels.
Caveolae are more dynamic in cells lacking EHD2
Caveolae have been described as relatively stable structures with 
the ability to undergo stimulated fission and endocytosis (Thomsen 
et al., 2002; Hommelgaard et al., 2005). However, in stable caveo-
lin1-GFP–expressing cells, a pool of caveolae was observed to be 
much more dynamic and to display a kiss-and-run behavior 
(Pelkmans and Zerial, 2005; Boucrot et al., 2011). To assay whether 
EHD2 was involved in regulating the dynamics of caveolae, we first 
used an ultrastructural assay (Kirkham, 2005; Howes, 2010; Boucrot 
et al., 2011) to quantify the number of budded caveolae. This assay 
relies on internalization of cholera toxin B-subunit–horseradish per-
FIGURE 6: Ultrastructural characterization showing loss of surface-
connected caveolae following overexpression of EHD2. (A) BHK cells 
were transfected with the indicated constructs, surface-labeled with 
ruthenium red, and then processed for Epon embedding. Caveolae 
were defined as ruthenium red–labeled, uncoated, circular profiles of 
55- to 75-nm diameter. High expression of GFP-EHD2 causes 
formation of surface-connected tubules of ∼45-nm diameter (arrows). 
In addition, tubules within the cytoplasm that are not surface 
connected are also evident (white arrows). Some tubules appeared 
coated (double arrows). Cells expressing the GFP-EHD2 T94A mutant 
(T94A) showed a range of morphologies, including caveolae similar to 
GFP control cells, small tubular caveolae, and in highly expressing 
aggregate-containing cells, loss of caveolae. PM, plasma membrane. 
(B) Bar graph showing the quantification of the number of surface-
connected caveolae per cell profile in GFP-EHD2– or GFP-EHD2 
T94A–expressing cells compared with GFP control cells as the mean 
of three independent quantifications. Error bars represent SEM. 
Highly expressing GFP-EHD2 cells, containing prominent aggregates, 
were excluded.
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FIGURE 7: EHD2 is not required for the formation of caveolae. (A) 3T3-L1 cells were treated with siRNA against EHD2 
or three different cavin1 siRNAs or control siRNA. Cell lysates (top, left and bottom panels) or immunoprecipitates (top, 
right) obtained using EHD2 antibodies antibodies (top, right panel) were subjected to SDS–PAGE and analyzed by 
immunoblotting with the indicated antibodies. (B) Fluorescence micrographs of cells treated with siRNA against EHD2 
or control siRNA and stained for EHD2 or caveolin1. Note that the monoclonal antibody against caveolin1 reacted 
poorly toward caveolin1 in mouse 3T3-L1 cells, so we were not able to detect endogenous EHD2 and caveolin1 in the 
same cell. (C) Cells treated as in (A), or overexpressing GFP-EHD2, were lysed and either boiled directly in sample buffer 
(total) or detergent-resistant membranes (DRM) were separated from cytosol and soluble membranes (supernatant) by 
centrifugation. Fractions were analyzed by immunoblotting using the indicated antibodies. The total level of caveolin1 in 
EHD2-depleted cells was 132 ± 18% compared with control cells, as determined from three independent experiments. 
Error values represent SEM. (D) Bar graph showing quantification of the EHD2 and cavin1 fraction in detergent-resistant 
membranes in control cells and cells depleted of EHD2 or cavin1. Immunoblots of EHD2 and cavin1 from three 
individual experiments as in (C) were quantified and scored as percentage of total protein. Error bars show SD. 
(E) Control cells and cells depleted of EHD2 were treated with 10 mM MβCD for 20 min to deplete caveolae. MβCD was 
washed out, and cells were fixed and stained for EHD2 or caveolin1 at the indicated time points. Note that caveolin1 
staining recovered similarly in the absence and presence of EHD2. All scale bars: 10 μm.
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and cavin-dependent manner (Bastiani and Parton, 2010). While ca-
veolin1 might induce membrane curvature of caveolae via oligomer-
ization and its stable integration in the membrane (Parton and Si-
mons, 2007; Hayer et al., 2010a), cavin1–4 form peripherally 
associated multiprotein complexes that regulate the morphology 
and dynamics of caveolae (Hill et al., 2008; Bastiani et al., 2009; 
Hansen et al., 2009; McMahon et al., 2009). Together with pacsin2, 
EHD2 is the first-described caveola-associated peripheral protein 
with biochemically defined, membrane-remodeling activity. Interest-
ingly, EHD2 oligomers in vitro were found to adopt rings of varying 
diameter that closely matched the distinct size of caveolae (Daumke 
et al., 2007). We show that caveolar membranes are remodeled into 
long tubules in the complete absence of ATP hydrolysis in EHD2. In 
addition, overexpression of EHD2, without overexpression of caveo-
lin1, resulted in loss and distortion of endogenous surface caveolae. 
This indicates that without the restraints of other proteins and ATP 
hydrolysis, the membrane-sculpting activity of EHD2 affects caveolar 
morphology. However, we found no effect on caveolar morphology 
following EHD2 depletion, suggesting that EHD2 is not essential for 
shaping caveolae.
EHD2 specifically associates with cell surface–connected caveo-
lae. Such structures are formed even in the absence of EHD2, indi-
cating that EHD2 is not required for the generation of caveolae, but 
rather is involved in stabilizing or controlling the dynamics of cave-
olae. We found that overexpression of EHD2 results in higher levels 
of overexpressed caveolin1 at the cell surface. In addition, depletion 
of EHD2 increased the number of internalized caveolae, supporting 
a stabilizing role of EHD2 at the plasma membrane. Caveolae can 
be endocytosed, but these structures appear to be very stable when 
compared with other invaginations, such as clathrin-coated pits 
(Thomsen et al., 2002; Hommelgaard et al., 2005). The nearly 
1000-fold-slower nucleotide hydrolysis rate of EHD2, as compared 
with dynamin (Daumke et al., 2007), might be optimized for the slow 
dynamics of caveolar turnover. Assembly of EHD2 oligomeric rings 
around caveolae might function as a cap to temporally control dy-
namin spiral formation and fission, as suggested for lamprey EHD1 
in the synapse (Jakobsson et al., 2011). A distinct pool of caveolae 
in stably expressing caveolin-GFP cells has been described to be 
highly dynamic (Pelkmans and Zerial, 2005; Boucrot et al., 2011). 
These short-lived caveolae were shown to contain cavin and to have 
a residence time of only a few seconds at the plasma membrane. It 
is plausible that EHD2 is required to stabilize the kiss-and-run be-
havior of such caveolae. Indeed, we found that without functional 
EHD2, caveolin1-RFP formed numerous short-lived structures at the 
surface. However, expression of EHD2 constrained caveolin1-RFP 
into structures that were very stable spatially and temporally.
Taken together, our observations suggest that EHD2 is involved 
in stabilizing caveolar assemblies and regulating subsequent turn-
over of caveolae. EHD2 might cooperate with dynamin, which was 
previously shown to localize to caveolar necks and to promote ca-
veolar fission, thereby controlling the stability of caveolae at the cell 
surface (Henley et al., 1998; Oh et al., 1998; Boucrot et al., 2011). 
Indeed, pacsin2 and other membrane-remodeling, BAR domain–
containing proteins have been shown to interact and function both 
with EHDs and dynamin (Braun et al., 2005; Pant et al., 2009; Senju 
et al., 2011) and might coordinate the suggested functional cross-
talk. While EHD2, cavin, and caveolin1 were stably associated at the 
membrane, pacsin2 only colocalized with a subset of these struc-
tures, indicating that the interaction between EHD2 and pacsin2 is 
temporally regulated and might be important for specific events in 
caveolar dynamics. EHD2 has also been described as binding other 
NPF-containing proteins, including rabenosyn-5 (Naslavsky et al., 
2004), prohibitin (Ande and Mishra, 2010), EHDBP1 (Guilherme 
et al., 2004), myoferlins (Doherty et al., 2008; Posey et al., 2011), 
and epsin1/3 (Ko et al., 2010). Our observation that EHD2-positive 
caveolae are limited in diffusion in the membrane suggests that 
these invaginations might be coupled to the cytoskeleton via such 
binding partners. Further definition of the proteome network around 
EHD2 will clarify its precise role at caveolae.
In summary, the presented data, together with previous work, 
support a model in which ATP-loaded EHD2 dimers are recruited to 
plasma membrane–associated caveolae to stabilize and control 
membrane curvature and fission of caveolae in an ATP hydrolysis–
dependent manner. This novel caveolar marker provides mechanis-
tic support for the process involved in the dynamics of such invagi-
nations, knowledge of which is vital for our general understanding 
of the physiological significance of caveolae.
MATERIALS AND METHODS
Reagents and constructs
Polyclonal antibodies against full-length EHD2 were generated and 
affinity-purified using recombinant EHD2. Purchased antibodies 
were: mouse anti-myc clone 9E10 and rabbit anti-myc from Cell Sig-
naling Technology (Danvers, MA); rabbit anti-caveolin1 (ab2910), 
rabbit anti-cavin1/PTRF, mouse anti-EEA1 (ab2900), and mouse 
anti-calnexin (ab22595) from Abcam (Cambridge, MA); mouse anti-
caveolin1 clone 2234 from BD Transduction Laboratories (Franklin 
Lakes, NJ); mouse anti–AP-1 from Sigma-Aldrich (St. Louis, MO); 
mouse anti-MHC class I (w6/32) from the American Type Culture 
Collection (Manassas, VA); mouse anti-MPR6R and mouse anti-AP-2 
(AP6) from Affinity BioReagents (Golden, CO); and rabbit anti-pac-
sin2 from BioSite, Mira Mesa, CA. All secondary antibodies were 
conjugated to Alexa Fluor 488, 546, or 647 (Invitrogen, Carlsbad, 
CA). cDNA constructs encoding human and mouse EHD2 and de-
rivatives were described previously (Daumke et al., 2007), except for 
the mutants F122A and ΔEH F122A, which were created using PCR-
directed mutagenesis (Stratagene; Agilent, Santa Clara, CA). cDNAs 
from EHD1, EHD3, and EHD4 (a kind gift of M. Plomann, University 
of Cologne) were cloned into the pSKB-LNB vector for expression 
as N-terminal His fusions in Escherichia coli, and into the pEGFP-C3 
vector for overexpression in eukaryotic cell culture. Constructs of 
GFP-tagged cavin1–4 were previously described (Bastiani et al., 
2009). RFP-tagged caveolin1 (14434; Tagawa et al., 2005) and 
DSred-tagged Rab9 (12677), Rab11 (12662), and Rab7 (12680; 
Choudhury et al., 2002) were purchased from Addgene (Cambridge, 
MA). GFP-flotillin was a kind gift from Ben Nichols (Laboratory of 
Molecular Biology, Cambridge). Stealth technology siRNA for EHD2 
and Cavin1 knockdown was purchased from Invitrogen.
Human EHD2 siRNA: ACAAGAUCCGCGUGGUGCUCAA-
CAA; mouse EHD2 siRNA: UUGAGUUUGCGGAAGGGCUUCU-
CUG; control siRNA: CAGCGAAUUCCCGCCCAAAUGACAA; 
mouse Cavin1 siRNAa: CCGCUGUCUACAAGGUGCCGCCUUU; 
mouse Cavin1 siRNAb: GCCGCAACUUCAAAGUCAUGAUCUA; 
mouse Cavin1 siRNAc: CACACGCUGGAGAAGCGCAUGAACA.
Protein purification, biochemical analysis, and ITC
EHD constructs were expressed in a BL21 (DE3) Rosetta E. coli strain 
as N-terminal His fusions and purified via affinity chromatography, 
as previously described (Daumke et al., 2007). Pacsin2 constructs 
were expressed as N-terminal GST fusions, followed by a thrombin 
cleavage site in Rosetta DE3 cells (Modregger et al., 2000). Cells 
were lysed in 50 mM HEPES (pH 7.5), 400 mM NaCl, 2.5 mM dithio-
threitol (DTT), 1 mM Pefablock (Roth, Karlsruhe, Germany), 1 μg/ml 
DNAseI (Sigma) using a microfluidizer. A soluble extract, prepared 
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FIGURE 8: Caveolae are more dynamic in cells depleted of EHD2. (A) Representative images of 3T3-L1 cells transfected 
with scrambled siRNA or EHD2 siRNA and incubated with CTxB-HRP as in (B). Arrows show 55-to 75-nm, CTxB-HRP–
positive budded caveolae containing the electron-dense DAB reaction product. Scale bar: 200 nm. Inset shows higher 
magnification of labeled and unlabeled caveolae. (B) 3T3-L1 cells were transfected with scrambled siRNA control or 
EHD2 siRNA, or left untransfected and treated with dynasore before addition of CTxB-HRP on ice and incubation at 
37°C for 1 min. The number of electron-dense, CTxB-HRP–positive carriers was quantified per cell across 29–32 cells in 
three independent experiments and distinguished based on size (55–75 nm being caveolae and 80–120 nm being 
clathrin-coated vesicles) and morphology (caveolae being uncoated). Error bars show SEM. Two-tailed t tests were 
performed for each set of data to determine significance. ** = p < 0.01. (C) Ruthenium red–stained 3T3-L1 cells were 
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a VP-ITC (MicroCal, Piscataway, NJ) in 20 mM HEPES (pH 7.5), 300 
mM NaCl, 2.5 mM DTT, 2 mM MgCl2, and 1 mM CaCl2 at the indi-
cated protein and ligand concentrations. Binding isotherms were 
fitted, and equilibrium dissociation constants were calculated using 
MicroCal ORIGIN software.
Cell culture, protein overexpression, and siRNA knockdown
3T3-L1 BHK, and HeLa cells were grown in DMEM medium (GIBCO, 
Grand Island, NY) supplemented with 10% fetal calf serum and 
transfected using Lipofectamine 2000 (Invitrogen) for transient pro-
tein expression. For EHD2 and cavin depletion, HeLa and 3T3-L1 
cells were transfected with stealth siRNA specific against human or 
mouse EHD2 and cavin1, respectively, using Lipofectamine 2000 
(Invitrogen), according to manufacturer’s instructions. If not other-
wise mentioned, 3T3-L1 cells were retransfected for optimal knock-
down and supplied with fresh DMEM medium every day. Optimal 
knockdown was achieved after 2–3 d, as identified by SDS–PAGE 
and immunoblotting. Cholesterol was depleted from 3T3-L1 cells 
using 10 mM MβCD (Sigma-Aldrich) in DMEM medium for indicated 
time intervals. To observe regrowth of caveolae, cells were incu-
bated with 10 mM MβCD in DMEM medium for 15 min and then 
washed out by using fresh DMEM medium and cells were incubated 
at 37°C, as indicated.
Immunofluorescence microscopy
For immunofluorescence analysis, HeLa and 3T3-L1 cells were fixed 
in 3% paraformaldehyde in phosphate-buffered saline (PBS) for 20 
min at room temperature, then washed and blocked in 5% goat se-
rum with 0.05% saponin in PBS before staining with the appropriate 
antibodies in 1% goat serum, 0.05% saponin in PBS using standard 
protocols. For immunofluorescence trafficking assays in HeLa cells, 
Alexa Fluor 568–conjugated transferrin (Invitrogen) was diluted in 
prewarmed media, added to cells, and incubated for the indicated 
time periods and temperatures. After washing, cells were fixed and 
subjected to immunofluorescence analysis, as described above. 
Epifluorescence images were taken using a Zeiss Axio Imager Z1 
system with AxioVision software (Zeiss, Jena, Germany). For live-cell 
confocal microscopy, cells were grown and transfected according to 
standard protocols on uncoated MatTek dishes, and then placed in 
a temperature-controlled chamber at 37°C with 95% air/5% CO2 
and 100% humidity (Okolab, Ottaviano, Italy). Live-cell imaging data 
were acquired using a fully motorized inverted microscope (Nikon 
A1R Laser Scanning Confocal Microscope) with a 60× oil immersion 
lens (Plan Apochromat VC; Nikon, Tokyo, Japan) under control of 
the NIS-Elements microscope imaging software (Nikon). For FRAP 
experiments, the region of interest was photobleached for 10 s 
using a 488 laser. Single images were taken every 10 s before and 
after photobleaching, and recovery intensity was measured for a 
total of 10 min. TIRF microscopy was performed using a Plan Apo-
chromat 100× oil objective lens, numerical aperture (NA) 1.49. Im-
ages were acquired with an iXon-897 electron-multiplying charge-
coupled device (EMCCD) camera (Andor, Belfast, Northern Ireland). 
by centrifugation at 50,000 × g for 45 min at 4°C, was applied on a 
glutathione-Sepharose column, which was extensively washed with 
washing buffer I (20 mM HEPES, pH 7.5, 300 mM NaCl, 2.5 mM 
DTT) and later with 20 mM HEPES (pH 7.5), 700 mM NaCl, 2.5 mM 
DTT, 5 mM KH2PO4, 5 mM K2HPO4, 0.5 mM ATP, to remove Hsp70 
contaminations. The GST tag was removed by addition of 500 U 
Thrombin (Serva, Heidelberg, Germany) in washing buffer 1 and 
overnight cycling at slow speed at 4°C. Cleaved protein was con-
centrated using ultrafiltration concentrators (molecular weight cutoff 
50 kDa; Millipore, Billerica, MA) and applied on a Superdex200 
26/60 gel-filtration column equilibrated with 20 mM HEPES 
(pH 7.5), 300 mM NaCl, 2.5 mM DTT for final purification.
To obtain lung lysates and membranes enriched for caveolae, 
mouse lungs were homogenized using a motor-driven glass homog-
enization in a HN150 (HEPES 25 mM, NaCl 150 mM) buffer supple-
mented with protease inhibitors. After initial centrifugation for 5 min 
at 800 × g to remove cell debris, the supernatant was centrifuged 
for 1 h at 60,000 rpm, and the supernatant was used as lung lysate. 
To obtain caveolae-enriched membranes, the pellet fraction (P1) 
was dissolved in HN150 supplemented with ice-cold 1% Triton 
X-100 for 30 min at 4°C and centrifuged for 10 min at 800 × g. The 
supernatant was adjusted to 40% sucrose, overlaid with 30 and 5% 
sucrose cushions, and centrifuged for 3 h at 39,000 rpm, and the 
30–5% interphase was collected. The P1 pellet fraction was solubi-
lized in HEPES 25 mM supplemented with 0.5% NP-40 and 300 mM 
NaCl, 1 mM DTT, and 5 mM EDTA and centrifuged at 20,000 × g for 
20 min to obtain membrane extract. For immunoprecipitations and 
pull-down experiments, antibodies or proteins were coupled to to-
sylactivated Dynabeads (Invitrogen). Beads were incubated with the 
indicated lysate at 4°C for 2–4 h, washed twice in NH150 buffer with 
0.1% Triton X-100 and once in NH150, boiled in sample buffer, and 
analyzed by SDS–PAGE and Coomassie stain or immunoblotting. 
For analysis of protein expression and efficiency of knockdown, 3T3-
L1 or HeLa cells were lysed using 1% Triton and HN150 buffer sup-
plemented with protease inhibitors for 30 min on ice, then centri-
fuged 20 min at 14,000 rpm at 4°C. Supernatants or pellets 
(detergent-resistant membranes) were analyzed by SDS–PAGE and 
immunoblotting. For analysis of total protein expression following 
overexpression of EHD variants, cells were sedimented, washed, 
and boiled directly in sample buffer before analysis by immunoblot-
ting. For determination of cytosolic and membrane-bound fractions, 
control or MβCD-treated 3T3-L1 cells were harvested, washed, and 
frozen/thawed twice in buffer containing 25 mM HEPES, 85 mM 
sucrose, 1 mM MgCl, and 100 mM potassium acetate. Disrupted 
cells were assessed by trypan blue stain. Cells were centrifuged at 
1500 rpm for 5 min, the pellet was washed and centrifuged again, 
and supernatants were pooled and boiled in sample buffer (cytosol). 
The pellet was dissolved in 1% NP40 and centrifuged at 1500 rpm 
for 5 min to spin down nuclei. The supernatant was centrifuged at 
60,000 rpm for 1 h, and the pellet was boiled in sample buffer (total 
membranes). Mouse tissue lysates were generated as described 
above for lung lysates. ITC experiments were carried out at 10°C in 
transfected with scrambled siRNA control or EHD2 siRNA, or left untransfected and treated with dynasore. The number 
of ruthenium red–labeled, and thus surface-connected, caveolae and clathrin-coated vesicles (Surface profiles) were 
counted per cell in 30–32 cells across three independent experiments. Error bars show SEM. Two-tailed t tests were 
performed for each set of data to determine significance. * = p < 0.05; ** = p < 0.01; ns, not significant. 
(D) Representative images from TIRF microscopy movie of cells cotransfected with GFP-EHD2 and caveolin-RFP or 
GFP-EHD2 K328 and caveolin1-RFP. Images were taken every 50 ms. Scale bars: 1 μm. (E) Proposed model for specific 
ATP-driven recruitment of EHD2 to caveolae via the KPF loop and subsequent oligomerization to stabilize caveolae at 
the surface. ATP hydrolysis–dependent disassembly of EHD2 is proposed to control oligomerization and thereby the 
dynamics of caveolae.
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Single images were taken every 0.05 s. TIRF microscopy with com-
bined epifluorescence microscopy experiments was performed with 
an Axio Observer Z1 TIRF3 system (Zeiss) with motorized TIRF-slider, 
using a Plan Apochromat 100× oil objective, NA 1.46. Images were 
acquired and analyzed by AxioVision software and a quantEM 
512SC EMCCD camera (Photometrics, Tucson, AZ). Single images 
were taken every 0.2 s.
Electron microscopy
Samples were processed for Tokuyasu embedding and immuno-
gold labeling using modifications of standard methods (Slot and 
Geuze, 2007), as described previously (Martin and Parton, 2008). 
Preparation and immunogold labeling of plasma membrane lawns 
from differentiated 3T3-L1 adipocytes were performed as described 
previously (Parton et al., 2002). For analysis and quantification of the 
effect of overexpression or depletion of EHD2 on surface ultrastruc-
ture, BHK cells were transfected with GFP, GFP-EHD2, or GFP-EHD2 
T94A and assayed after overnight incubation, or 3T3-L1 cells were 
transfected with scrambled siRNA or EHD2 siRNA, or were left un-
transfected and were treated with 80 μM dynasore (Sigma-Aldrich) 
for 30 min at 37°C. For quantification of caveolar density, BHK or 
3T3-L1 cells were washed twice in PBS before fixation in 2.5% glu-
taraldehyde and 1 mg/ml ruthenium red for 1 h at room tempera-
ture to highlight the cell surface. Cells were washed in 0.1 M caco-
dylate buffer before fixation in 1% osmium tetroxide with 1 mg/ml 
ruthenium red for 3 h at room temperature and processed by con-
ventional methods for Epon embedding. Ultrathin sections (55–
60 nm) were cut perpendicular to the substratum (vertical sections) 
to give an unbiased representation of the entire plasma membrane. 
Quantification of surface caveolae was performed on random areas 
along the monolayer. Surface caveolae were defined as ruthenium 
red–labeled 55- to 75-nm uncoated circular profiles, as in previous 
studies. By these criteria, caveolae are absent from Cav1−/− cells. 
Each area was then used for quantification by moving along the 
monolayer in a random manner. For BHK cells, the results are from 
two independent transfections with four separate areas of the 
monolayer selected for analysis, with a total of > 45 cell profiles ana-
lyzed for each condition. For 3T3-L1 cells, the results are from three 
independent transfections with four separate areas of the mono-
layer selected for analysis, with a total of >30 cell profiles analyzed 
for each condition. For CTxB-HRP uptake assays, 3T3-L1 cells were 
transfected with scrambled siRNA or EHD2 siRNA, or were left un-
transfected and were treated with 80 μM dynasore (Sigma-Aldrich) 
for 30 min at 37°C. Cells were cooled on ice in ice-cold washing buf-
fer (CO2-independent media [Life Technologies, Grand Island, NY] 
supplemented with 1% BSA) before being bound with 10 μg/ml 
CTxB-HRP (Invitrogen) in ice-cold washing buffer for 30 min at 4°C. 
Samples were washed twice in washing buffer before incubation in 
prewarmed growth media (DMEM [Life Technologies]), 10% fetal 
bovine serum, 2 mM l-glutamine) for 1 min at 37°C. Cells were 
placed back on ice, washed in ice-cold washing buffer, and incu-
bated with 1 mg/ml DAB with 50 μM ascorbic acid for 10 min. 
DAB solution was exchanged with DAB, ascorbic acid with 0.012% 
H2O2 for a further 20 min prior to fixation in 2.5% glutaraldehyde. 
Samples were processed for conventional LX112/epon (ProSciTech, 
Townsville, Queensland, Australia) embedded transmission electron 
microscopy, as previously described (Howes et al., 2010).
Image and statistical analysis
For quantification of colocalization, 3–10 separate images of each 
condition were thresholded for the brightest areas; overlapping 
areas were then transferred into a new channel, and the percent 
colocalization area was calculated using Adobe Photoshop (San 
Jose, CA). To quantify the correlation of different stains, the Intensity 
Correlation Analysis plug-in for ImageJ was used to generate PDM 
(product of the differences from the mean) images and intensity 
correlation quotient (ICQ) correlation values. Schematic tracking of 
EHD2 and caveolin1 structures captured by TIRF microscopy was 
done manually using Adobe Photoshop. Measuring and counting of 
EHD2-positive tubules was done using AxioVision software. FRAP 
experiments were analyzed and processed using the NIS-Elements 
microscope imaging software. Intensity of bands identified by 
immunoblotting was quantified using ImageJ. Bar graphs and statis-
tical analysis were performed using GraphPad Prism (La Jolla, CA).
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